ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

PET Response Can Predict Increased Survival In Patients

April 27, 2012

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994